EA200000556A1 - METHOD OF PREVENTING CHRONIC HEART FAILURE IN PULMONARY TUBERCULOSIS PATIENTS - Google Patents

METHOD OF PREVENTING CHRONIC HEART FAILURE IN PULMONARY TUBERCULOSIS PATIENTS

Info

Publication number
EA200000556A1
EA200000556A1 EA200000556A EA200000556A EA200000556A1 EA 200000556 A1 EA200000556 A1 EA 200000556A1 EA 200000556 A EA200000556 A EA 200000556A EA 200000556 A EA200000556 A EA 200000556A EA 200000556 A1 EA200000556 A1 EA 200000556A1
Authority
EA
Eurasian Patent Office
Prior art keywords
heart failure
chronic heart
pulmonary tuberculosis
preventing chronic
patients
Prior art date
Application number
EA200000556A
Other languages
Russian (ru)
Other versions
EA004677B1 (en
Inventor
Александр Елизарович Дитятков
Александр Николаевич Красноперов
Александр Эдуардович Радзевич
Виктор Александрович Тихонов
Original Assignee
Александр Николаевич Красноперов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Александр Николаевич Красноперов filed Critical Александр Николаевич Красноперов
Priority to EA200000556A priority Critical patent/EA004677B1/en
Publication of EA200000556A1 publication Critical patent/EA200000556A1/en
Publication of EA004677B1 publication Critical patent/EA004677B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Использование: во фтизиатрии: для вторичной профилактики хронической сердечной недостаточности у больных туберкулезом легких. Сущность изобретения: применяют комплексное лечение в сочетании полноценной противотуберкулезной химиотерапии с одновременным воздействием препарата ингибитора ангиотензинпревращающего фермента - престариума. Практическое применение предлагаемого изобретения осуществлено при лечении 16 больных.Usage: in phthisiology: for the secondary prevention of chronic heart failure in patients with pulmonary tuberculosis. The essence of the invention: apply a comprehensive treatment in combination with a full-fledged anti-tuberculosis chemotherapy with the simultaneous effects of the drug angiotensin-converting enzyme inhibitor - prestarium. The practical application of the invention carried out in the treatment of 16 patients.

EA200000556A 2000-03-07 2000-03-07 Method of prophylaxis of chronic cardiac insufficiency in patients suffering from pulmonary tuberculosis EA004677B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA200000556A EA004677B1 (en) 2000-03-07 2000-03-07 Method of prophylaxis of chronic cardiac insufficiency in patients suffering from pulmonary tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA200000556A EA004677B1 (en) 2000-03-07 2000-03-07 Method of prophylaxis of chronic cardiac insufficiency in patients suffering from pulmonary tuberculosis

Publications (2)

Publication Number Publication Date
EA200000556A1 true EA200000556A1 (en) 2001-10-22
EA004677B1 EA004677B1 (en) 2004-06-24

Family

ID=32798658

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000556A EA004677B1 (en) 2000-03-07 2000-03-07 Method of prophylaxis of chronic cardiac insufficiency in patients suffering from pulmonary tuberculosis

Country Status (1)

Country Link
EA (1) EA004677B1 (en)

Also Published As

Publication number Publication date
EA004677B1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
EE200200086A (en) Use of a renin-angiotensin system inhibitor, a combined product, and a method for preventing cardiovascular events
SE9702860D0 (en) New use
RS50091B (en) Use of retigabine for the treatment of neuropathic pain
WO2003090695A3 (en) TREATMENT OF α-GALACTOSIDASE A DEFICIENCY
ES2178157T3 (en) TREATMENT OF ARRITMIAS THROUGH THE INHIBITION OF A MULTIFUNCTIONAL KINASE PROTEIN DEPENDENT ON CALCIUM / CALMODULIN.
BRPI0413974A (en) combination, method of treating cancer in a warm-blooded animal, pharmaceutical composition, and, use of a combination
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
YU63699A (en) Compositions for treating and preventing arterial thrombosis and use of a factor xa inhibitor on its own and/or combined with a platelet antiaggregating agent
MXPA05003253A (en) Novel pyrimidineamide derivatives and the use thereof.
PT998287E (en) USES OF LEVOBUPIVACAINE
WO2001041754A8 (en) Inhibitors of collagen-induced platelet aggregation
NO993670D0 (en) Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as a drug for the treatment of AIDS
CO5700723A2 (en) USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY
SE9603725D0 (en) New teatment
EP1099442A3 (en) Methods of administering apo B-secretion/MTP inhibitors
GB0328180D0 (en) Combination
EE03517B1 (en) New medical use of ACE inhibitors for the treatment of dyspeptic symptoms
NO20042758L (en) Procedure for treating a patient requiring analgesia.
ATE187890T1 (en) LIGAND DIRECTED ENZYME PRODRUG THERAPY
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
EA200000556A1 (en) METHOD OF PREVENTING CHRONIC HEART FAILURE IN PULMONARY TUBERCULOSIS PATIENTS
FI20020197A0 (en) A combination treatment method for acute myocardial infarction
GB9930075D0 (en) Medicaments
NO981320L (en) Oral use of (+) - O-demethyltramadol as a pain reliever
NO20042586L (en) Treatment Progress Mate

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU